Latest news
Loading news…
Alcobra Pharmaceuticals Inc. which is developing a treatment for attention deficit hyperactivity disorder (ADHD).
Alcobra Pharmaceuticals was acquired by Arcturus Therapeutics in 2017.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Tel Aviv, Israel
4
professional contacts at Alcobra Pharmaceuticals
Contact execs at Alcobra Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Alcobra Pharmaceuticals
Loading news…
FAQs about Alcobra Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.